Surrozen Inc.

NASDAQ: SRZNW · Real-Time Price · USD
0.02
0.00 (23.46%)
At close: Apr 29, 2025, 10:53 AM
23.46%
Bid n/a
Market Cap 79.75M
Revenue (ttm) 10.65M
Net Income (ttm) -63.56M
EPS (ttm) -5.695
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask n/a
Volume 100
Avg. Volume (20D) 19,722.2
Open 0.02
Previous Close 0.02
Day's Range 0.02 - 0.02
52-Week Range 0.02 - 0.02
Beta 0.69

About SRZNW

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its pro...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 10, 2021
Employees 40
Stock Exchange NASDAQ
Ticker Symbol SRZNW
Full Company Profile
No News article available yet